2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-02-08 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 14649468 2023-02-08 2024-02-28 14649468 2024-02-28 14649468 2023-02-07 14649468 bus:Director1 2023-02-08 2024-02-28 14649468 core:WithinOneYear 2024-02-28 14649468 core:RetainedEarningsAccumulatedLosses 2024-02-28 14649468 bus:SmallEntities 2023-02-08 2024-02-28 14649468 bus:AuditExemptWithAccountantsReport 2023-02-08 2024-02-28 14649468 bus:SmallCompaniesRegimeForAccounts 2023-02-08 2024-02-28 14649468 bus:PrivateLimitedCompanyLtd 2023-02-08 2024-02-28 14649468 bus:FullAccounts 2023-02-08 2024-02-28 14649468 core:KeyManagementPersonnel 2023-02-08 2024-02-28
COMPANY REGISTRATION NUMBER: 14649468
PHYLAX TECHNOLOGIES LIMITED
Filleted Unaudited Financial Statements
28 February 2024
PHYLAX TECHNOLOGIES LIMITED
Financial Statements
Period from 8 February 2023 to 28 February 2024
Contents
Page
Statement of financial position
1
Notes to the financial statements
2
PHYLAX TECHNOLOGIES LIMITED
Statement of Financial Position
28 February 2024
28 Feb 24
Note
£
£
Current assets
Debtors
5
932
Cash at bank and in hand
22,217
--------
23,149
Creditors: amounts falling due within one year
6
7,152
--------
Net current assets
15,997
--------
Total assets less current liabilities
15,997
--------
Net assets
15,997
--------
Capital and reserves
Profit and loss account
15,997
--------
Shareholders funds
15,997
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 1 November 2024 , and are signed on behalf of the board by:
Dr J D Galson
Director
Company registration number: 14649468
PHYLAX TECHNOLOGIES LIMITED
Notes to the Financial Statements
Period from 8 February 2023 to 28 February 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Camburgh House, 27 New Dover Road, Canterbury, Kent, CT1 3DN, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
After making appropriate enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future for at least one year from the date of the financial information. For these reasons they continue to adopt the going concern basis in preparing the company's financial information.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 2 .
5. Debtors
28 Feb 24
£
Other debtors
932
----
6. Creditors: amounts falling due within one year
28 Feb 24
£
Corporation tax
3,752
Other creditors
3,400
-------
7,152
-------
7. Related party transactions
At the year end, the company owed a director £2,000.